Data shows COVID-19 vaccines are creating a pathway to a strong U.S. recovery
The successful development and distribution of the COVID-19 vaccines have given newfound hope in the U.S. that the pandemic may be waning.
The successful development and distribution of the COVID-19 vaccines have given newfound hope in the U.S. that the pandemic may be waning.
As we head into the Fourth of July weekend, Americans are reemerging from the COVID-19 pandemic with heightened hopes and confidence in a strong U.S. recovery. The COVID-19 vaccines have been credited with the steep decline in cases nationwide as we reach the lowest rates since the earliest stages of the pandemic. Reliance on safe, effective vaccines can continue to move the needle as we work to control the virus and protect against evolving variants. In 15 states and the District of Columbia, at least 70% of adults have received at least one dose of a COVID-19 vaccine, which is promising news.
Below are additional data points to keep in mind as we all work together to end the COVID-19 pandemic.
Americans are confident in the biopharmaceutical industry.
Following emergency use authorization allowing for use of one COVID-19 vaccine for children ages 12-15 years of age, parent confidence is increasing.
While building vaccine confidence among a smaller percentage of the overall U.S. population continues to be a challenge, there is clear potential to close the gap.
While there is more work to be done to get all eligible Americans vaccinated, the successful development and distribution of the COVID-19 vaccines have given newfound hope in the U.S. that the pandemic may be waning. As more and more Americans receive vaccinations, and coronavirus infections, deaths and hospitalization rates plummet, strengthening vaccine confidence and trust is our best solution to effectively control the pandemic and reopen safely and effectively.